These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 1678580)
61. Carvedilol in hypertension: effects on hemodynamics and 24-hour blood pressure. Lund-Johansen P; Omvik P; Nordrehaug JE; White W J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S27-34. PubMed ID: 1378146 [TBL] [Abstract][Full Text] [Related]
62. Celiprolol in the treatment of hypertension: a comparison with propranolol. Taylor SH; Beattie A; Silke B J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S127-31. PubMed ID: 2427842 [TBL] [Abstract][Full Text] [Related]
63. Celiprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in cardiovascular disease. Milne RJ; Buckley MM Drugs; 1991 Jun; 41(6):941-69. PubMed ID: 1715268 [TBL] [Abstract][Full Text] [Related]
64. Immediate and short-term hemodynamic effects of diltiazem in patients with hypertension. Amodeo C; Kobrin I; Ventura HO; Messerli FH; Frohlich ED Circulation; 1986 Jan; 73(1):108-13. PubMed ID: 3510085 [TBL] [Abstract][Full Text] [Related]
65. Effects of celiprolol on reflex control of the cardiovascular system in essential hypertension. Mancia G; Grassi G; Parati G; Pomidossi G; Sabadini E; Giannattasio C; Bolla G; Zanchetti A J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S67-74. PubMed ID: 2427855 [TBL] [Abstract][Full Text] [Related]
66. Effects of celiprolol on plasma renin, aldosterone, norepinephrine and epinephrine in primary hypertension. Kimura S; DeQuattro V; Hernandez PH; Lee DD Am J Cardiol; 1988 Oct; 62(10 Pt 1):751-4. PubMed ID: 2971310 [TBL] [Abstract][Full Text] [Related]
67. Cardiovascular effects of beta-blockers with and without intrinsic sympathomimetic activity. A comparison between celiprolol and metoprolol. Heusser K; Schobel HP; Adamidis A; Fischer T; Frank H Kidney Blood Press Res; 2002; 25(1):34-41. PubMed ID: 11834875 [TBL] [Abstract][Full Text] [Related]
68. A placebo-controlled double-blind multicenter study of celiprolol in the treatment of mild and moderate hypertension. Capone P; Mayol R J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S119-21. PubMed ID: 2427840 [TBL] [Abstract][Full Text] [Related]
70. Renal and systemic effects of atenolol and tertatolol in renal transplant recipients on cyclosporine A. Branten AJ; Hilbrands LB; van Hamersvelt HW; Koene RA; Huysmans FT Nephrol Dial Transplant; 1998 Feb; 13(2):423-6. PubMed ID: 9509456 [TBL] [Abstract][Full Text] [Related]
71. [Celiprolol in the treatment of chronic stable angina]. Román O; Cuevas G; Martínez D; Vargas W Rev Med Chil; 1991 Jan; 119(1):50-5. PubMed ID: 1688095 [TBL] [Abstract][Full Text] [Related]
72. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina. Silke B; Verma SP; Frais MA; Reynolds G; Taylor SH Clin Pharmacol Ther; 1986 Jan; 39(1):5-14. PubMed ID: 2935349 [TBL] [Abstract][Full Text] [Related]
73. [Are beta-blockers generally contraindicated in patients with peripheral arterial occlusive disease?]. Schweizer J; Kaulen R; Altmann E; Nierade A; Nanning T Z Kardiol; 1996 Mar; 85(3):193-7. PubMed ID: 8659199 [TBL] [Abstract][Full Text] [Related]
74. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination]. Brandstetter G; Hoffmann H Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831 [TBL] [Abstract][Full Text] [Related]
75. Quality of life before and during antihypertensive treatment: a comparative study of celiprolol and atenolol. Cleophas TJ; van der Mey N; van der Meulen J; Niemeyer MG Int J Clin Pharmacol Ther; 1996 Jul; 34(7):312-7. PubMed ID: 8832309 [TBL] [Abstract][Full Text] [Related]
76. [Left ventricular function in hypertension. Echographic evaluation before and after beta blockade (atenolol)]. Dany F; Lagrée S; Clémenty J; Prague Y; Salamon R; Dallocchio M Arch Mal Coeur Vaiss; 1979 Jun; 72(6):662-8. PubMed ID: 40535 [No Abstract] [Full Text] [Related]
77. Cardiovascular mass and ventricular function after celiprolol in Wistar-Kyoto and spontaneously hypertensive rats. Horinaka S; Frohlich ED Cardiovasc Res; 1992 Apr; 26(4):396-400. PubMed ID: 1353414 [TBL] [Abstract][Full Text] [Related]
78. Antihypertensive mechanism of beta-adrenoceptor antagonism--the role of beta 2-blockade. Dahlöf B; Andrén L; Svensson A; Hansson L J Hypertens Suppl; 1983 Dec; 1(2):112-5. PubMed ID: 6152739 [TBL] [Abstract][Full Text] [Related]
79. Hemodynamic consequences of long-term beta-blocker therapy: a 5-year follow-up study of atenolol. Lund-Johansen P J Cardiovasc Pharmacol; 1979; 1(5):487-95. PubMed ID: 94405 [TBL] [Abstract][Full Text] [Related]
80. [Hemodynamic effects of intravenously administered celiprolol in patient with coronary heart disease and depressed left ventricular function]. Leisch F; Herbinger W Arzneimittelforschung; 1987 Apr; 37(4):444-6. PubMed ID: 2886131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]